Does reticulocyte synthesize RNA ?

As has been well established, reticulocytes (RC) synthesize the species specific protein, globin, actively for about 24 hours or more till the time of their complete maturation1,2,3. This will be possible only in the presence of messenger RNA (m-RNA)4,5. Since the splendid hypothesis of m-RNA proposed by JACOB and MONOD6 for explaining the mechanism of the transfer of genetic information from nucleus to cytoplasm, it has largely been accepted through the numerous observations that followed7,8,9,10. However, the m-RNA hypothesis, which has been deduced by observing the protein synthesis in E. Coli, includes the meaning of labile RNA which is incessantly decomposed and newly synthesized to compensate the rapid degradation. As m-RNA cannot be synthesized in RC which have no detectable DNA, it has been supposed that the m-RNA of RC should be considerably stablell,12,13. Even in the denucleated cells, however, the RNA synthesis might be possible because Borsook reported the positive RNA synthesis of RC14, and this result has recently been reconfirmed by BURNY15.</p

Surface Modification with Metal Hexacyanoferrates for Expanding the Choice of H₂-Evolving Photocatalysts for Both Fe³⁺/Fe²⁺ Redox-Mediated and Interparticle Z-Scheme Water-Splitting Systems

The construction of Z-scheme water splitting systems is an effective approach toward harvesting a wide portion of the solar light spectrum; however, the success has often depended on the property of photocatalyst surfaces. This drawback is typified by the limited choice of efficient H₂ evolution photocatalysts (HEPs) (e.g., Rh-doped SrTiO₃) for Z-scheme water splitting using Fe³⁺/Fe²⁺ redox couple. The majority of visible light-responsive materials shows low activity for H2 production with Fe²⁺ electron donors despite having suitable band levels, probably due to the absence of an effective surface site for oxidizing Fe²⁺. The choice of HEPs for interparticle Z-scheme systems has also been limited. Herein, an effective strategy for overcoming these limitations is reported: activation of originally inactive materials via surface modification with metal hexacyanoferrate nanoparticles. Photocatalytic H2 evolution over TaON in aqueous Fe²⁺ solution is drastically enhanced by comodification with indium hexacyanoferrate (InHCF) and Rh–Cr mixed oxide. InHCF promotes Fe²⁺ oxidation to Fe³⁺ utilizing the holes photogenerated in TaON via FeIII/FeII redox cycles, enabling Z-scheme water splitting with the Fe³⁺/Fe²⁺ redox mediator coupled with an O2 evolution photocatalyst under visible light. It is also disclosed that InHCF nanoparticles function as effective solid electron mediators for achieving interparticle Z-scheme water splitting

Glacial fjord environment and ecosystem reconstructed from sediments deposited in Bowdoin Fjord, northwestern Greenland.

The Tenth Symposium on Polar Science/Ordinary sessions: [OG] Polar Geosciences, Wed. 4 Dec. / 3F Seminar room, National Institute of Polar Researc

前立腺癌における血清γ-セミノプロティンの測定

前立腺癌の新しいマーカーとして, γ-セミノプロテイン(γ-Sm)と前立腺性酸性ホスファターゼ(PAP)とを比較評価した.未治療前立腺癌におけるγ-SMおよびPAPのsensitivityは, それぞれ81%, 67%であった.γ-Smはすべての病期で前立腺肥大症と比較して陽性率が高かった.前立腺癌ではγ-SmとPAPは相関を示さなかった.γ-SmとPAPを同時に測定することにより, 感度が上昇した.γ-SmおよびPAPのspecificityはそれぞれ87%と90%であった.内分泌療法を施行した病期D2において, γ-SmはPAPよりもより多く正常化した.以上より, γ-Smは前立腺癌のもう1つの有用なマーカーであるといえるSerum gamma-seminoprotein (gamma-Sm) was evaluated as a new marker for prostatic cancer in comparison with prostatic acid phosphatase (PAP). The sensitivity of gamma-Sm and PAP for untreated prostatic cancer was 81% and 67%, respectively. gamma-Sm showed a higher positive rate over all stages than in benign prostatic hypertrophy (BPH). There was no correlation between gamma-Sm and PAP in prostatic cancer. Improved sensitivity was obtained by simultaneous measurement of gamma-Sm and PAP. Specificity of gamma-Sm and PAP for BPH was 87% and 90%, respectively. gamma-Sm normalized after endocrine therapy for stage D2 more often than did PAP. These results indicate that gamma-Sm is another useful marker to evaluate prostatic cancer